Case Reports in Pulmonology
Volume 2012 (2012), Article ID 214601, 4 pages
A Case of Follicular Bronchiolitis as the Histological Counterpart to Nodular Opacities in Bronchiectatic Mycobacterium avium Complex Disease
1Division of Respiratory Medicine, National Hospital Organization Omuta Hospital, 1044-1 Oaza Tachibana, Omuta City 837-0911, Japan
2Department of Respiratory Medicine, Fukuoka University Chikushi Hospital, 1-1-1 zokumyouin, Chikucino City 818-8502, Japan
3Division of Radiology, National Hospital Organization Omuta Hospital, 1044-1 Oaza Tachibana, Omuta City 837-0911, Japan
Received 23 August 2012; Accepted 30 September 2012
Academic Editors: L. Borderías, H. Kobayashi, and D. T. Merrick
Copyright © 2012 Kentaro Wakamatsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Here we report the case of a 72-year-old woman with nodular bronchiectatic Mycobacterium avium complex (MAC) disease. Chest computed tomography on admission revealed multiple micronodular and branching opacities in both lobes with segmental distribution; bronchiectasis and bronchial wall thickening were observed in the middle lobe and lingula. The patient consented to and underwent thoracoscopic lung biopsy; epithelioid granulomas were occasionally observed, but follicular bronchiolitis was widespread. While bronchial lesions from nontuberculous mycobacterial infection generally present as epitheliod granulomas, the present case suggests that follicular bronchiolitis can also be a histological counterpart to nodular opacities in nodular bronchiectatic MAC disease.
The estimated prevalence of pulmonary nontuberculous mycobacterial (NTM) infection in Japan is more than 5.7 per 100,000 population, a high level even by international standards . Of particular interest is the recent increase in nodular bronchiectatic Mycobacterium avium complex (MAC) disease [1–3]. While previous reports have revealed these bronchial lesions to be histologically granulomatous after operation of nodular bronchiectatic MAC pharmacotherapy [4–7], there have been those which examine radiological-histological correlation on the nodules before treatment. Here we report a case in which follicular bronchiolitis was the histological counterpart to nodular opacities of nodular bronchiectatic MAC disease as assessed by diagnostic biopsy.
2. Case Report
The patient was a 72-year-old woman with chief complaints of coughing and sputum. Her medical history revealed hypertension from 10 years before; family history was unremarkable. Social history was as follows: smoking (no), drinking (social), allergies (none), pet ownership history (none), use of down blankets (no), use of humidifier (yes), use of Kampo medicine or health foods (no), dust inhalation history (none), and occupation (seaweed harvesting).
2.1. Current Medical History
Despite being informed of abnormal opacities on a chest X-ray in July 2004, she refused treatment. On April 10, 2006, she experienced a 38°C fever and headache (no coughing or sputum) and visited a local clinic the next day. Chest X-ray revealed abnormal opacities; white blood cell (WBC) 9800 and C-reactive protein (CRP) 6+ suggested a pronounced inflammatory response. She was diagnosed with pneumonia and administered levofloxacin (LVFX), clarithromycin (CAM), and ceftriaxone (CTRX). Inflammation resolved by April 15 (WBC 4800 and CRP 1+), although abnormal opacities remained on the chest X-ray. Right chest pain, coughing, and sputum (no fever) appeared on May 25. She was administered CTRX upon revisiting the clinic, but WBC (10500) and CRP (6+) did not improve. She was referred to our hospital and admitted on May 29.
The patient was alert on admission. Characteristics were as follows: height 142.0 cm, weight 41.0 kg. BMI 20.9 kg/m2, blood pressure 144/93 mmHg, pulse 82 beats per min, and body temperature 35.7°C. There was no palpable swelling in the superficial lymph nodes, and no signs of skin lesions, edema, cyanosis, or head or neck abnormalities. Heart and breathing sounds were normal. Liver and spleen were not palpable. There were no neurological findings.
Findings on admission are summarized in Table 1. WBC and biochemical tests were normal, but CRP was high (2.1 mg/dL). Rheumatoid factor and antinuclear antibodies were mildly increased. Chest X-ray on admission revealed nodular and infiltrative opacities in both lung fields. Chest CT on admission revealed multiple micronodular and branching opacities presenting with segmental distribution in right S2 and S3, right S6 and S9, and the left upper lobe (Figure 1(a)). There was increased lung density with volume loss in the middle lobe and lingula, as well as bronchiectasis and bronchial wall thickening.
2.2. Progress after Admission
NTM infection was suspected from imaging findings on admission. Sputum cultures were negative for three consecutive days. Bronchofiberscopy on June 7 revealed no abnormal findings in the visible range. Sputum smears remained negative for acid fast bacilli (AFB) after bronchial washing of right B2, B5, and B6 and bronchial brushing of B2 and B5. After conferring with the patient, thoracoscopic lung biopsy of S6 was carried out on June 22 for definitive diagnosis (Figure 1(c)). While epithelioid granulomas with occasional Langhans giant cells were observed (Figure 2), the main finding was fibrosis and lymphocytic aggregates in the airways, that is, follicular bronchiolitis. Lung specimens were AFB smear-negative. On June 7, bronchial lavage fluid cultures were AFB smear positive; M. intracellulare was confirmed by polymerase chain reaction (PCR). The patient was placed on watchful waiting; chest X-ray and CT on June 21 revealed strengthening of micronodular densities. She underwent bronchoscopy on August 21, 2007. AFB smears were positive after bronchial washing of right B2, B5, and B6 and bronchial scraping of right B2 and B5. PCR on bronchial lavage fluid confirmed the presence of M. intracellulare. On August 21, 2007, she was started on rifampicin 450 mg/day, ethambutol (EB) 500 mg/day, CAM 600 mg/day, and amikacin (AMK) 400 mg/day. Abnormal findings on CT and X-rays (e.g., bronchial lesions) subsequently improved.
Among the various types of pulmonary MAC disease are nodular bronchiectatic type, fibrocavitary type, hot tub lung type, and disseminated type [8, 9]. The recent rise of pulmonary MAC disease in Japan can be attributed to the nodular bronchiectatic type [1, 2]. This type had been reported by Yamamoto in 1970 as bronchiectatic and by Shimoide in 1980 as the middle lobe/lingual type or the chronic bronchitis type [10, 11]. Yet, it was only after Prince et al. reported its clinical manifestations in 1989 that the disease received widespread attention . According to Prince et al., the nodular bronchiectatic type occurs frequently in middle-aged women and is associated with persistent cough, purulent sputum, predominant slowly progressive nodular opacities, and, albeit rarely, cavitary disease.
MAC classically involves the middle lobe and lingula, and in many cases, it can be bilateral from the outset. Imaging typically reveals the presence of micronodules and its aggregation and consolidation in peripheral (subpleural) lung fields, drainage bronchus wall thickening and bronchiectasis, and lung volume loss . Lesions have a strong tendency for S5 than S4, and the cavity formation is rarely observed in the same lobe . When involving surrounding lobes, lesions commonly spread to S2, S3, and S6. Although cavities are formed with bronchogenic spread of lesions as in tuberculosis, the cavity rarely enlarges. Lymph node and pleural lesions are also rare . In the present case, chest CT revealed multiple micronodular and branching opacities presenting with segmental distribution in right S2 and S3, right S6 and S9, and the left upper lobe. There was also increased lung density associated with volume loss in the middle lobe and lingula, as well as bronchiectasis and bronchial wall thickening. These findings suggest that the present case is typical of nodular bronchiectatic type.
Fujita et al. reported the analysis of resected lung specimens from 5 patients with drug-administered fibrocavitary MAC disease, finding that nodules 5 mm on CT were 2-3 mm granulomas consisting of mononuclear and epithelioid cells . Inflammatory infiltration of alveolar walls and caseous necrosis in the center of the granulomas in nodules 10 mm, lymphocyte infiltration in the bronchial submucosa extending from the bronchioli to acini, and extensive epithelioid cell infiltration have also been reported [5, 14]. Hebisawa et al. reported macroscopic and pathological findings from surgical specimens obtained from drug-administered patients with nodular bronchiectatic MAC disease and concluded that the most characteristic lesion is bronchiectasis. Epithelioid cell granulomas are occasionally observed within the high degree of small round cell infiltration, and airway ulcers are also seen in the thickened airway wall. Hebisawa et al. further reported granulomatous bronchitis and bronchiolitis associated with obstruction and stenosis of the bronchial lumen due to proliferative and sclerosing granuloma at the dilated distal bronchi, and a few nonspecific bronchiolitis associated with follicular bronchiolitis and small round cell infiltration with prominent lymph follicles [4, 6, 7]. In the present case, granulomatous lesions were minimal, and the main bronchiolar lesion was follicular bronchiolitis. The discrepancy with previous reports can be explained by the fact that Fujita et al. analyzed nodular lesions in fibrocavitary MAC disease, and Hebisawa et al. analyzed nodular opacities associated with severe bronchiectatic change. Thus, these studies may not reflect the histopathological features of centrilobular nodular opacities often seen in nodular bronchiectatic MAC disease by CT. In addition, the pathological specimens were obtained before treatment in our case, while those studies used resected specimens from drug-administered patients.
Many potential causes of follicular bronchiolitis have been reported, including connective tissue diseases such as rheumatoid arthritis and Sjogren’s syndrome, immunodeficiency, hypersensitivity disorders such as hypereosinophilic syndrome, and chronic airway inflammation [15, 16]. There were no findings suggestive of connective tissue disorder or immunodeficiency in the present case, and given the lack of increased eosinophils, this strongly suggested the possibility of follicular bronchiolitis due to chronic airway inflammation by M. intracellulare.
To our knowledge, this is a first report on the pathological examination of biopsies of centrilobular nodular lesions in nodular bronchiectatic MAC disease prior to therapy.
Conflict of Interests
The authors declare that they have no conflict of interests.
- A. Kurashima, “New diagnosis and treatment for nontuberculous mycobacterial infection,” Japanese Journal of Chest Diseases, vol. 68, pp. 999–1012, 2009.
- The Japanese Society for Tuberculosis Nontuberculous Mycobacterial Infection Task Force, “Views on diagnosis of nontuberculous mycobacterial infection-2003,” Kekkaku, vol. 78, pp. 569–572, 2003.
- D. S. Prince, D. D. Peterson, R. M. Steiner et al., “Infection with Mycobacterium avium complex in patients without predisposing conditions,” The New England Journal of Medicine, vol. 321, no. 13, pp. 863–868, 1989.
- A. Hebisawa, A. Tamura, Y. Sagara, and A. Kurashima, “he pathology of pulmonary nontuberculous mycobacterial infection,” Japanese Journal of Chest Diseases, vol. 59, pp. 565–577, 2000.
- J. Fujita, Y. Ohtsuki, E. Shigeto et al., “Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex,” Respiratory Medicine, vol. 97, no. 8, pp. 933–938, 2003.
- A. Hebisawa, K. Tsuchiya, and A. Tamura, “Pulmonary Mycobacterium aviumcomplex disease,” Pathology and Clinical Medicine, vol. 23, pp. 501–508, 2005.
- A. Hebisawa, K. Asakawa, A. Tamura, E. Takeuti, and Y. Nakajima, “The pathology of Mycobacterium avium-complex disease,” Japanese Journal of Chest Diseases, vol. 68, pp. 1032–1045, 2009.
- D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007.
- S. Akagawa, “Chest X-ray image findings of Mycobacterium avium complex (MAC) lung disease,” Kekkaku, vol. 84, no. 8, pp. 569–575, 2009.
- M. Yamamoto, Nontuberculous Mycobacterial Infection, Kanehara, Tokyo, Japan.
- H. Shimoide, “Clinical research on nontuberculous mycobacterial infection,” Japanese Journal of Chest Diseases, vol. 39, pp. 866–877, 1980.
- E. Tanaka, R. Amitani, and F. Kuze, “The current state and future of Mycobacterium avium-complex disease. Clinical study on M. avium-complex disease,” Kekkaku, vol. 68, pp. 57–61, 1993.
- M. Okumura, H. Ogata, and T. Mori, “Mycobacterial disease—differentiating tuberculosis from nontuberculous mycobacterial infection,” Respiratory Medicine, vol. 8, pp. 43–48, 2005.
- J. Fujita, Y. Ohtsuki, I. Suemitsu et al., “Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease,” European Respiratory Journal, vol. 13, no. 3, pp. 535–540, 1999.
- S. A. Yousem, T. V. Colby, and C. B. Carrington, “Follicular bronchitis/bronchiolitis,” Human Pathology, vol. 16, no. 7, pp. 700–706, 1985.
- W. D. Travis and J. R. Galvin, “Non-neoplastic pulmonary lymphoid lesions,” Thorax, vol. 56, no. 12, pp. 964–971, 2001.